Global Research Output of Lutetium-177 PSMA in Prostate Cancer: Bibliometric and Altmetric Analyses.
Globale Forschungsergebnisse zu Lutetium-177-PSMA bei Prostatakrebs: bibliometrische und altmetrische Analysen.
Journal
Nuklearmedizin. Nuclear medicine
ISSN: 2567-6407
Titre abrégé: Nuklearmedizin
Pays: Germany
ID NLM: 7609387
Informations de publication
Date de publication:
23 Jan 2024
23 Jan 2024
Historique:
medline:
24
1
2024
pubmed:
24
1
2024
entrez:
23
1
2024
Statut:
aheadofprint
Résumé
The integration of innovative radio-pharmaceutical agents targeting prostate-specific membrane antigen (PSMA) within nuclear medicine has transformed prostate cancer detection and management. This study aims to investigate the present landscape of [ We systematically probed the Scopus repository for relevant [ Spanning January 2015 to July 2023, the study encompassed 466 articles concerning [ The findings highlight the growing interest and advancements in the utilization of [
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Informations de copyright
Thieme. All rights reserved.
Déclaration de conflit d'intérêts
The authors declare that they have no conflict of interest.